Loading clinical trials...
Loading clinical trials...
A Randomized, Sham Controlled, Crossover Trial of rTMS for Bipolar Depression
To compare antidepressant efficacy of left or right to sham Repetitive Transcranial Magnetic Stimulation (rTMS) to determine if non-responders can become responders if treated on the other side of the hemisphere (rTMS)
Patients will be assigned to one of 3 treatment arms for 10 days of treatment with either left high frequency or right high frequency, or sham rTMS. After 10 days of treatment, and no improvement, another 10 days of treatment follows, this time with the coil placed on the other hemisphere. Subjects will be followed for 2 months respectively with unrestricted treatment provided by their regular physician. Mood stabilizers will be continued throughout this trial.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
St. Joseph's Healthcare, rTMS Laboratory, Mood Disorder Program, 100 West Fifth Street
Hamilton, Ontario, Canada
Start Date
July 1, 2002
Primary Completion Date
July 1, 2011
Completion Date
July 1, 2011
Last Updated
August 3, 2011
40
ESTIMATED participants
Transcranial Magnetic Stimulation (TMS)
DEVICE
Lead Sponsor
St. Joseph's Healthcare Hamilton
Collaborators
NCT06831435
NCT07463911
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions